Net (Elk-3, Sap-2, Erp) and the related ternary complex factors Elk-1 and Sap-1 are effectors of multiple signalling pathways at the transcriptional level and play a key role in the dynamic regulation of gene expression. Net is distinct from Elk-1 and Sap-1, in that it is a strong repressor of transcription that is converted to an activator by the Ras/Erk signalling pathway. Two autonomous repression domains of Net, the NID and the CID, mediate repression. We have previously shown that the corepressor CtBP is implicated in repression by the CID. In this report we show that repression by the NID involves a different pathway, sumoylation by Ubc9 and PIAS1. PIAS1 interacts with the NID in the two-hybrid assay and in vitro. Ubc9 and PIAS1 stimulate sumoylation in vivo of lysine 162 in the NID. Sumoylation of lysine 162 increases repression by Net and decreases the positive activity of Net. These results increase our understanding of how one of the ternary complex factors regulates transcription, and contribute to the understanding of how different domains of a transcription factor participate in the complexity of regulation of gene expression.
Introduction
The ternary complex transcription factors (TCFs) are the targets of multiple signalling pathways and have important roles in the regulation of key cellular functions (for reviews, see Shaw and Saxton, 2003; Yang et al., 2003b; Buchwalter et al., 2004) . The molecular mechanisms involved in the regulation of these factors have been extensively studied and the TCFs have become a paradigm for the study of transcriptional regulation in response to extracellular signalling, especially through the MAP kinase pathway. The three TCFs, Net (also called Elk-3, Erp, Sap-2), Elk-1, and Sap-1 form a subfamily of the Ets-domain transcription factors. Their characteristic property is the ability to form a ternary nucleoprotein complex with the serum response factor (SRF) over the serum response element of the c-fos promoter. The TCFs have three similar regions, A-C. The N-terminal A domain corresponds to the Ets DNA-binding domain, the B domain interacts with SRF, the C-terminal C domain is an activation domain that is turned on by phosphorylation by MAP kinases. Net is distinct among the TCFs in that it is a strong repressor in the absence of activation by MAP kinase signalling (Giovane et al., 1994) . Activation of the ERK signalling pathway converts Net to an activator of transcription. Repression by Net is thought to maintain target promoters in an inactive state in the absence of positive signalling. Repression by Net is mediated by two inhibitory domains, the net inhibitory domain (NID) and the CtBP interaction domain (CID). The CID contains a sequence that interacts with the corepressor CtBP1 (E1A C-terminalbinding protein), which acts as a corepressor through a mechanism involving recruitment of HDAC (histone deacetylase) and de-acetylation of chromatin (Criqui-Filipe et al., 1999) . A variety of transcription factors contain related CtBP-binding sequences (Chinnadurai, 2002 (Chinnadurai, , 2003 . The NID is an autonomous inhibitory domain that lies adjacent to the B box (Maira et al., 1996) . However, the molecular mechanisms by which the NID represses transcription are poorly defined. We have performed a yeast two-hybrid screen to identify factors that interact with the NID. The prevalent interacting protein, the protein inhibitor of activated STAT1 (PIAS1), was particularly intriguing.
PIAS1 was originally identified as a factor that binds to STAT1 and inhibits its transactivational activity (for reviews, see Melchior et al., 2003; Schmidt and Muller, 2003; Seeler and Dejean, 2003; Verger et al., 2003; Johnson, 2004; Muller et al., 2004) . PIAS1 and the other four related PIAS family members function as transcriptional co-regulators in several important cellular pathways, including Wnt, p53 and steroid hormone receptors. This transcriptional activity is functionally linked to their E3 ligase activity, which stimulates the attachment of SUMO to proteins. The three SUMO proteins (1-3) are 92-97 amino-acid polypeptides that resemble ubiquitin and are covalently conjugated to lysines. Sumoylation resembles ubiquitylation in that it involves an E1-activating enzyme (the Aos1/Uba2 heterodimer), an E2-conjugating enzyme (Ubc9), and an E3 ligase that promotes the transfer of SUMO from the E2 enzyme to substrates. In addition to the PIASs, there are two other SUMO E3 ligases: the polycomb protein Pc2 and the nuclear pore component RanBP2. SUMO modification is reversed by SUMO-specific isopeptidases.
We show here that PIAS1 interacts with the NID and stimulates its sumoylation on lysine 162. Sumoylation increases the repressor activity of Net and decreases its ability to stimulate transcription upon activation by Ras expression. These results show that different factors are involved in repression by the two inhibitory domains of Net, and provide important insights into the mechanisms of regulation through this important transcription factor.
Results

PIAS1 interacts with the NID domain of Net
The yeast two-hybrid system was used to identify factors that interact with the central region of Net, which contains the NID and the CID inhibitory domains and lacks the A DNA-binding domain and C transactivation domain (LexA-dAC, Figure 1a) . A screen of a mouse embryo library, corresponding to days E9.5E-E12.5 when Net is expressed, gave 223 positive clones, of which the largest group contained PIAS1 sequences (61/223). We used a b-galactosidase assay to confirm the specificity of the interaction and to delimit the region of Net that interacts with PIAS1 ( Figure 1b) . Full-length Net (LexA-Net) interacted with PIAS1 more efficiently than a number of controls LexA fusion proteins (LexABicoid, . LexA-dAC interacted more efficiently with PIAS1 than full-length Net. We previously reported a similar observation for CtBP1 (Criqui-Filipe et al., 1999) , and provided evidence that it results from Net adopting a 'closed' conformation that inhibits interactions (Maira et al., 1996; Criqui-Filipe et al., 1999) . Deletion mutants, containing separately the three principle functional elements of the central region, showed that the NID interacts with PIAS1 (LexA-NC2), whereas the B-domain (LaxA-C10) and the CID (LexA-NC4) do not. We also tested variants of Net that are expressed from spliced RNAs (Giovane et al. (1997) and data not shown). LexA-Net b and LexA-Net c interacted with PIAS1, whereas LexA-Net a did not, as expected from the presence or absence of the NID.
We also studied the interaction between the NID and PIAS1 in vitro. GST and GST-Net fusion proteins were synthesized in bacteria, immobilized on glutathioneagarose beads and incubated with in vitro translated PIAS1 (Figure 1c ). GST-Net fusions containing the NID retained PIAS1 (GST-dAC, GST-NC2; lanes 3 and 5), whereas the other GST proteins did not (lanes 2, 4 and 6), showing that the NID interacts specifically with PIAS1 in vitro.
Net is sumoylated in vivo
The interactions of Net with Ubc9 (Hahn et al., 1997) and with PIAS1 (this report), which are E2 and E3 enzymes for SUMO, suggest that Net is modified by sumoylation. To test this possibility, Net was expressed in COS cells in the presence of increasing amounts of SUMO-1, and cell extracts were analysed by Western blotting with ant-Net and anti-SUMO-1 (Figure 2a) . The co-expression of SUMO-1 with Net resulted in the Sumoylation, PIAS1, and Net C Wasylyk et al appearance of a distinct band, with an apparent increase in size of about 15 kDa, as expected for the addition of a SUMO-1 moiety to Net (WB: Net; Net-SUMO, lanes 3 and 4). This band was not detected when Net or SUMO-1 were expressed alone (lanes 2 and 5). Reprobing the same membrane with anti-SUMO-1 detected this additional band, but only when Net and SUMO were coexpressed (WB: SUMO; compare lanes 3 and 4 with 1, 2 and 5). We performed co-immunoprecipitation (IP) assays to show that SUMO-1 is conjugated to Net. Cell extracts were boiled in the presence of SDS in order to dissociate noncovalently bound proteins, immunoprecipitated and Western blotted with the same antibody against Net (Figure 2b ). The Net-SUMO band was still detected in cells expressing both Net and SUMO-1 (Figure 2b , left upper panel, compare input and IP Net, lanes 3 and 4), but was not detected when only Net or SUMO-1 were expressed (lanes 1, 2 and 5; the faint band co-migrating with Net in the IP Net lanes 1 and 5 is probably immunoglobulin heavy chain from the IP). When the Net IP was Western blotted with anti-SUMO, the Net SUMO band was only detected in the cells coexpressing Net and SUMO (right panel). In the converse IP, using antibodies against the His tag of SUMO-1, the Net-SUMO band was detected on Western blots probed with anti-Net (lower panel). Sumoylation can be inhibited by dominant-negative Ubc9 (dnUbc 9) and the SUMO-specific protease Ssp3 (Yang et al., 2003a) . Expression of either Ssp3 or dnUbc9 decreased sumoylation of Net (Figure 2c , compare lanes 3 and 4 with 1 and 2). These results show that Net is sumoylated in vivo.
Lysine 162 in the NID is sumoylated
The NID contains two potential sumoylation sequences K Â E), corresponding to lysines 162 and 165 ( Figure 3a) . These lysines were mutated to arginines, individually (M1, M2) or together (M1 þ 2). In order to analyse the function consequences of these mutations on the transcriptional activity of Net without the effects of endogenous Ets proteins, we constructed fusion proteins that contain the Gal4 DNA-binding domain fused to different sequences of Net (Figure 3b ). Gal-N3 contains the NID, the CID, and the C-domain; in comparison Gal-N4 lacks the NID. Gal-N3 was sumoylated following co-expression of Net and SUMO-1 in COS cells ( Figure 3c , lanes 1 and 2), and sumoylation was inhibited by Ssp3 and dnUbc9 (lanes 3 and 4). Mutation of lysine 162 and deletion of the NID prevented sumoylation (Gal-N3-M1, lanes 5-8; Gal-N3-M1 þ 2, lanes 13-16; and Gal-N4, lanes 17-19), whereas mutation of lysine 165 had little effect (Gal-N3-M2, lanes 9-12). These results show that lysine 162 in the NID is a site of sumoylation in vivo.
PIAS1 stimulates Net lysine 162 sumoylation in vivo
PIAS1 is a SUMO E3 ligase and is therefore expected to stimulate Net sumoylation. We studied the effects of PIAS1 expression on Net sumoylation on lysine 162. These results show that PIAS1 stimulates sumoylation of Gal-N3 in vivo.
In order to investigate whether there are additional sumoylation sites in Net, the lysine-to-arginine mutations were introduced into the full-length protein. Coexpression of SUMO, Ubc9 and PIAS1 with Net led to the appearance of an additional band of the expected size for mono-sumoylated Net (Figure 4c , lanes 1 and 2; see Net-SUMO). Co-expression of Ssp3 or dnUbc9 prevented the appearance of the additional band (data not shown). Mutation of lysine 162 to arginine inhibited sumoylation (Net-M1, lanes 3 and 4), whereas mutation of lysine 165 did not prevent sumoylation (Net-M2, lanes 5 and 6). Mutation of both lysines also inhibited sumoylation (Net-M1 þ 2, lanes 7 and 8). An additional weaker band of the predicted size of di-sumoylated Net was also detected (lane 2, small arrowhead). This band was not observed with Net-M1 and Net-M1 þ 2 (lanes 4 and 8), but was present with Net-M2, raising the possibility that it is a modification of Net that is dependent upon lysine 162 but not lysine 165. The nature of this band, and other relatively minor bands (see lane 1 for an example), requires further investigation. Nevertheless, our results show that lysine 162 is the major sumoylation site of Net.
We searched for endogenous sumoylated Net in NIH3T3 cells by immunoprecipitation and Western blotting (Figure 4d ). We detected, by direct analysis of cell extracts with Western blots and Net antibodies, a distinct but minor band migrating at the position expected for sumoylated Net (lane 2; compare with the slightly larger His-tagged His-SUMO-Net in lane 1). A similar sized band was detected in anti-SUMO-1 immunoprecipitates (lane 4), but not in control immunoprecipitates with a nonspecific antibody (anti-Gal4, lane 3). These results indicate that a small proportion of endogenous Net is sumoylated in NIH3T3 cells.
Sumoylation of lysine 162 has a negative effect on transcription regulation by Net
The effects of sumoylation on transcription regulation by Net were studied following transfection in CHO-D cells, in which the transcription properties of Net have been extensively characterized (Criqui-Filipe et al., 1999) . The Gal4 reporter (UAS-Luc), the internal control (pSG5-LacZ) and Gal4-Net fusion proteins were co-transfected, and luciferase activities were corrected for any variations in the internal control. The experiments were repeated at least three times with two DNA preparations, and representative results of consistent effects are shown. As expected from previous Sumoylation, PIAS1, and Net C Wasylyk et al reports (Maira et al., 1996; Criqui-Filipe et al., 1999) , Gal-N3 inhibited transcription compared to Gal4 alone, and deletion of the NID partially relieved repression (Figure 5a , without Ras, compare Gal-N3 and Gal-N4 with Gal4). Ras expression converted Gal-N3 to an activator, and deletion of the NID further increased its activity (Figure 5a , with Ras, compare Gal-N3 and Gal-N4 with Gal4). Mutation of lysine 162 reproducibly relieved repression (M1 and M1 þ 2, without Ras), and increased transcriptional activation in the presence of Ras (with Ras), whereas mutation of lysine 165 had little effect (M2, without or with Ras). Inhibition of sumoylation with Ssp3 and dnUbc9 (Figure 5b ) increased the activity of Gal-N3, but had no effects on recombinants lacking lysine 162 due to mutation (Gal-N3-M1 and Gal-N3-M1 þ 2) or deletion of the NID (Gal-N4). These results show that sumoylation of lysine 162 has a negative effect on transcription regulation by Net.
We also studied the effects of sumoylation on the activity of the NID in the absence of other Net domains, and on the activity of the intact Net protein. Inhibition of sumoylation increased the activity of a Gal4-NID fusion protein (Figure 5c , Gal-NC2) to a similar extent as Gal-N3, whereas neither Gal4 alone nor Gal-N4 was sensitive to these inhibitors. Increasing concentrations of Net led to progressively greater inhibition of a Net reporter containing ets motifs (Figure 5d ). Inhibition of sumoylation led to decreased repression. These results show that sumoylation of lysine 162 in the NID has a negative effect on the activity of this element either in isolation, or in the context of other domains of Net.
Discussion
We have shown that Net is covalently modified with SUMO in vivo on lysine 162 in the NID. K162 lies within the sequence IKTE that fits with the consensus SUMO conjugation site (cK Â E, where c represents a large hydrophobic amino acid) (for reviews, see Melchior et al., 2003; Schmidt and Muller, 2003; Seeler and Dejean, 2003; Verger et al., 2003; Johnson, 2004; Muller et al., 2004) . The K in the overlapping sequence EKLE (Figure 3) is not sumoylated, as expected from the presence of the charged glutamic acid instead of a hydrophobic amino acid. PIAS1 (this report) and Ubc9 (Hahn et al., 1997) were isolated in a yeast two-hybrid screen as factors that interact with the central region of Net. PIAS1 was in fact the most highly represented clone in the screen. PIAS1 interacts with the NID in the two-hybrid screen as well as in vitro. Expression of PIAS1 or Ubc9 with SUMO-1 stimulates sumoylation Figure 4 PIAS1 enhances the sumoylation of Net in vivo. Cells were transfected (where indicated), lysed and analysed by Western blotting with a Net antibody (#375). (a) PIAS1 and Ubc9 enhance sumoylation of lysine 162 of Gal-N3 in COS-7 cells. The cells were transfected with expression vectors for Gal-N3 (1 mg pGal-N3, lanes 1-5), Gal-N3-M1 (1 mg pGAL-N3-M1, lane 6), SUMO-1 (0.1 mg pSG5-His-SUMO-GG, lanes 2-6), Ubc9 (0.1 mg pcDNA3-Ubch9, lanes 3, 5, 6) and PIAS1 (0.05 mg pTL1-PIAS1, lanes 4-6). Abbreviations: N3 ¼ Gal-N3, M1 ¼ Gal-N3-M1. (b) PIAS1 strongly stimulates Ubc9-enhanced sumoylation of Gal-N3 in NIH3T3 cells. NIH3T3 cells were transfected with expression vectors for Gal-N3 (1.0 mg pGal-N3, all lanes), SUMO-1 (0.125 mg pSG5-His-SUMO-GG, lanes 2-5), Ubc9 (0.5 mg pcDNA3-Ubch9, lanes 3, 5) and PIAS1 (0.05 mg pTL1-PIAS1, lanes 4, 5). (c) Lysine 162 is required for sumoylation of full-length Net. COS-7 cells were transfected with expression vectors for Net (1 mg pTL2-Net, lanes 1, 2), the Net mutants Net-M1, Net-M2, and Net-M1 þ 2 (1 mg pTL2-Net-M1, lanes 3, 4; 1 mg pTL2-Net-M2, lanes 5, 6; 1 mg pTL2-Net-M1 þ 2, lanes 7, 8), and SUMO, Ubc9, and PIAS1 (0.1 mg pSG5-His-SUMO-GG, 0.1 mg pcDNA3-Ubch9, 0.05 mg pTL1-PIAS1, lanes 2, 4, 6, 8). Sumoylation, PIAS1, and Net C Wasylyk et al of K162. PIAS1 is less efficient than Ubc9, especially in NIH3T3 cells. Exogenous PIAS1 presumably stimulates the activity of limiting endogenous Ubc9, which could account for its smaller effect. PIAS1 expression stimulates Ubc9-activated sumoylation, as expected for an E3 ligase (for reviews, see Melchior et al., 2003; Johnson, 2004) . However, further experiments are required to show that PIAS1 is an E3 ligase for Net in vivo. We found that a small percentage (less than 5%) of endogenous Net is sumoylated. A low level of sumoylation has been reported for endogenous Elk-1 (Yang et al., 2003a; Salinas et al., 2004) , and many other proteins, although the reasons for non-stoichiometric modification are still unclear (for a review, see Johnson, 2004) . Sumoylation of Net has effects on the transcriptional activity of the full-length protein as well as the isolated NID domain. Inhibition of sumoylation by different means, including mutation of lysine to arginine or expression of dnUbc9 or Ssp3 that inhibits lysine 162 sumoylation, influences the activity of Net. Interestingly, sumoylation of K162 affects both the negative and positive activities of Net: it increases repression and decreases activation. This suggests that sumoylation of K162 has a persistent negative effect on Net whether or not the factor is acting in a negative or positive mode. The M1 þ M2 mutant has a synergistical role on Net activity in the presence of Ras, suggesting that lys165, which has no effect on sumoylation, can have a role in transcriptional activity induced by Ras. In a number of other studies, SUMO modification has been found to correlate with either repression or attenuation of activation of transcription, and in certain cases the sumoylation sites have been shown to map to autologous repression domains (for a review, see Verger et al., 2003) . However, less frequently, sumoylation has been shown to stimulate the activity of transcription factors (Le Drean et al., 2002; Nishida and Yasuda, 2002) , possibly because of indirect effects. Our results would fit into a general model that is emerging to account for PIAS/SUMO-mediated repression (for reviews, see Melchior et al., 2003; Schmidt and Muller, 2003; Seeler and Dejean, 2003; Verger et al., 2003; Johnson, 2004; Muller et al., 2004) . PIAS proteins could be assembly factors for transcription co-regulatory complexes, as well as E3-like enzymes. They may form complexes with Ubc9 and SUMO on repression domains and thereby create scaffolds for the assembly of co-repressor complexes. There are various observations that point to this model. Ubc9 binds to SUMO (Gong et al., 1997) , sumoylation consensus sites (Sampson et al., 2001) , and PIAS CHO-D cells were transfected with the Gal4 responsive reporter (2 mg UASx5-Luc), the internal control (0.5 mg pSG5-LacZ), and expression vectors for Gal4, Gal4-Net fusion proteins (0.125 mg), the Ha-Ras oncoprotein (0.125 mg), Ssp3 (0.5, 1 or 2 mg) or dnUbc9 (0.5, 1 or 2 mg), as indicated. Abbreviations: dn, dnUbc ¼ dnUbc9;
Activities are expressed relative to Gal4 in (a), and to the activity of each Gal4-Net fusion protein in the absence of Ssp3 or dnUbc9 in (b). (c) The NID domain of Net is required for repression by SUMO. CHO-D cells were co-transfected with the Gal4 responsive reporter (2 mg UASx5-Luc), the internal control (0.5 mg pSG5-LacZ), and expression vectors for Gal4 (0.125 mg pGal4, bars 1-3), Gal4-Net fusion proteins (0.125 mg pGal-N3, bars 4-6; 0.125 mg pGal-NC2, bars 7-9; 0.125 mg pGal-N4, bars 10-12), Ssp3 (1 mg pCMV-Ssp3, bars 2, 5, 8, 11), dnUbc9 (1 mg pcDNA3-Ubch9-C93S, bars 3, 6, 9, 12) or the empty vector (1 mg pcDNA3, bars 1, 4, 7, 10). Activities are expressed relative to the corresponding Gal4 proteins in the absence of Ssp3 or dnUbc9. (d) Sumo-specific protease 3 (Ssp3) and dominant-negative Ubc9 (dnUbc9) relieve Net repression in vivo. CHO-D cells were co-transfected with an ets-responsive luciferase reporter (2 mg Palx8-TK-Luc containing 8 ets palindromic elements), an internal control (0.5 mg pSG5-LacZ), the empty vector (pTL2, bars 1-3), the Net expression vector (0.125 mg pTL2-Net, bars 4-6; 0.5 mg pTL2-Net, bars 7-9), the Ssp3 expression vector (1 mg pCMV-Ssp3, bars 2, 5 ,8), the dnUbc9 expression vector (1 mg pcDNA3-Ubch9-C93S, bars 3, 6, 9), or the corresponding empty vector (1 mg pcDNA3, bars 1, 3, 5) . Activities are expressed relative to the reporter with transfected Net (bar 1) proteins (Kotaja et al., 2002) . PIAS proteins and Ubc9 interact with various negative regulatory domains that are sumoylated. For example, the repressor function of Sp3 resides in a small inhibitory domain that binds to PIAS1 and is modified by SUMO (Sapetschnig et al., 2002) . Sumoylation of target proteins can enhance the interaction with PIAS proteins (Kotaja et al., 2002; Sapetschnig et al., 2002) . PIAS proteins possess intrinsic transcriptional activities when fused to a heterologous DNA-binding domain (Kotaja et al., 2000) . Furthermore, PIAS proteins interact with other factors associated with repression of transcription, including the nuclear matrix (Sachdev et al., 2001; Tan et al., 2002) and HDACs (Tussie-Luna et al., 2002; Long et al., 2003) . Sumoylation alone is not sufficient to account for repression by PIAS proteins (Sachdev et al., 2001; Megidish et al., 2002; Schmidt and Muller, 2002) . However, SUMO fused to a heterologous DNA-binding domain can repress transcription (Iniguez-Lluhi and Pearce, 2000; Kim et al., 2002; Ross et al., 2002; Yang et al., 2002) , suggesting that SUMO itself mediates at least part of the transcriptional effect. Interestingly, deletion of the NID has a greater effect than inhibition of sumoylation on the transcriptional activity of Net, suggesting that repression is more complex than just sumoylation. The overall emerging view applied to Net would suggest that sumoylated NID may assemble into a co-repressor complex through interactions with PIAS1 and Ubc9. The existence and composition of such complexes on Net or repression domains in other factors require further studies. In addition, other mechanisms cannot be excluded, since sumoylation has been associated with many processes, including localization to subnuclear structures such as PODs, nuclearcytoplasmic transport, replication, homologous recombination and base excision repair (for reviews, see Melchior et al., 2003; Schmidt and Muller, 2003; Seeler and Dejean, 2003; Verger et al., 2003; Johnson, 2004; Muller et al., 2004) . At least some of these functions of SUMO could influence the activity of Net. Interestingly, sumoylation of Elk-1 has also been shown to regulate nucleo-cytoplasmic shuttling (Salinas et al., 2004) .
The negative effects of NID sumoylation are observed with the isolated NID and in the context of other repressor and activator domains of Net, suggesting that the effects of sumoylation of the NID are at least to some extent independent of the activities of the other domains. Sumoylation of factors regulating other domains of Net could have had effects in our assays. The repressor domain CID interacts with CtBP1, which is sumoylated with the help of PIAS1 and PIAS xb (Lin et al., 2003) , as well as a different type of E3 enzyme, the polycomb protein Pc2 (Kagey et al., 2003) . In analogy with Elk-1 and Sap-1 (Janknecht and Nordheim, 1996a, b) , the activated C-domain of Net may interact with p300, which is a substrate for sumoylation (Girdwood et al., 2003) . We did not observe any effects of inhibition of sumoylation on the activity of Gal-N4, which contains the CID and the C-domain. However, we cannot exclude that there are effects that are not detected in our assays. Such effects could be promoter context dependent, as has been observed for C/EBPa (Subramanian et al., 2003) and the glucocorticoid receptor (Le Drean et al., 2002) .
Net belongs to a subfamily of related factors, the TCFs, which have many properties in common. Sap-1 has been suggested to have a NID-like repression domain (Sharrocks, 2002) . Interestingly, the putative NIDs of human, mouse and rat SAP-1 proteins contain consensus sumoylation sites, and a sequence alignment with human, mouse, rat, and Xenopus Net (Elk-3) proteins and the related TCF-1 from goldfish gives an extended conserved sequence F K Â I K Â E Â Â Â E Â Â Â E/D. Notably, the conserved sequence has an asymmetric and periodic distribution of oppositely charged amino acids. This sequence conservation suggests that the NIDs of Net and Sap-1 proteins have related functions and may interact with similar factors. Interestingly, the repressor domain of Elk-1 (R) that is also regulated by sumoylation does not have this extended consensus. Furthermore, sumoylation appears to be more crucially important for repression by the R domain (Yang et al., 2002) , and phosphorylation of the C-domain leads to loss of sumoylation (Yang et al., 2003a) . The involvement of PIAS proteins in R domain functions has not been reported. It remains to be seen how the mechanisms of repression by the NID and the R motif might be different. The TCFs are thought to bind to the same sites on promoters, and exchange between the TCFs may contribute to the dynamics of promoter regulation. It remains to be seen how sumoylation of their repression domains contributes to the complexity of regulation that results from this dynamic process.
In summary, we have added an important element to the understanding of how repression by the Net transcription factor is regulated, and thereby increased our understanding of the complex interplay between transcription factors and their domains in the regulation of gene expression in response to different signalling cascades.
Materials and methods
Plasmids
-LexA-Net fusion proteins (pLexA-Net, -dAC, -C10, -NC2, -NC4, -Net, -Net-a, -Net-b, -Net-c, -Bicoid, -Mash, -Myc, and -Cdc2; Figure 1 ): (Hahn et al., 1997; Criqui-Filipe et al., 1999) . LexA-Bicoid, -Mash, -Myc, and -Cdc2 were generous gifts from R Brent.
-Prokaryotic GST fusion proteins (GST-dAC, -C10, -NC2, and -NC4): (Criqui-Filipe et al., 1999) .
-pTL1-PIAS1: the Klenow-filled Sfi I fragment from pASV3-clone 3 (isolated in the yeast two-hybrid screen and identified as full-length mouse PIAS1) in the SmaI site of pTL1 (Criqui-Filipe et al., 1999) .
-Gal4-Net fusion proteins: pGal-N3 and pGal-N4 (Maira et al., 1996) . pGal-N3-M1 (K162R), pGal-N3-M2 (K165R), and pGal-N3-M1 þ 2 (K162R, K165R) were made with the Quick-Change kit (Stratagene) and the sequences were confirmed.
-Net expression vectors: pTL2-Net-M1 (K162R), pTL2-Net-M2 (K165R), and pTL2-Net-M1 þ 2 (K162R, K165R) were made from pTL2-Net (Criqui-Filipe et al., 1999) with the Quick-Change kit (Stratagene) and the sequences were confirmed.
-pSG5-His-SUMO-GG, pSG5-SUMO-GG: a generous gift from F Lehembre and A Dejean.
-pCMV-Ssp3 (HMp222), pcDNA3-Ubch9, and pcDNA3-Ubch9-C93S (dnUbc9): a generous gift from RT Hay.
-Palx8-TK-Luc (Criqui-Filipe et al., 1999).
-UAS-TK-Luc: a generous gift from Dr A Bradford and Professor A Gutierrez-Hartmann.
-pSG5-LacZ: IGBMC core facility.
Yeast two-hybrid, b-galactosidase interaction assays, in vitro protein-protein interactions
The yeast two hybrid assay, in which PIAS1 was isolated, was described previously (Criqui-Filipe et al., 1999) . The conditions for b-galactosidase interaction assays in yeast, GST protein synthesis, expression, and in-vitro interaction assays were as described (Criqui-Filipe et al., 1999) .
Cell culture and transfections
COS-7 cells were maintained in Dulbecco's modified Eagle's medium (Sigma) supplemented with 5% FCS. CHO-D cells were cultured in a-MEM 1900 (Sigma) medium plus 10% FCS and 20 mM glutamine. Cells were transfected by the BBS calcium phosphate method (Chen and Okayama, 1987) in either 90 mm dishes with 20 mg of DNA for COS-7 cells (IP), or in six well plates with 4 mg of DNA for CHO-D cells. At 18 h after adding the precipitate, the cells were washed twice with FCS-free medium and incubated for 24 h in 0.05% FCS medium. The cells were scraped in 1 ml of phosphate-buffered saline (PBS) and processed for protein studies (COS-7) or luciferase and b-galactosidase assays (CHO-D). Luciferase assays were performed with the Luciferase Assay System from Promega according to the manufacturer's instructions and analysed with a Luminometer (EG&G Berthold). Luciferase activity was corrected for the transfection efficiency using bgalactosidase activity as an internal control. At least two independently prepared DNAs were tested. Each experiment was performed at least three times, and one representative experiment is shown.
Western blots and antibodies
Proteins, obtained by lysing the cells directly in loading buffer in the presence of 20 mM DTT, 10 mM PMSF, protease inhibitors, and 20 mM N-ethyl maleimide, were fractionated by SDS-PAGE and transferred to nitrocellulose membranes. After 1 h of saturation in PBSTM (PBS with 0.05% Tween-20 and 3% milk), the membranes were incubated overnight at 41C with specific primary antibodies in PBSTM þ 0.5% milk, washed four times for 5 min with PBST, incubated for 1 h at room temperature with secondary antibodies coupled to peroxidase (diluted 1/5000) in PBSTM þ 0.5% milk, washed four times for 5 min and revealed with the ECL detection Kit (Amersham, Ref RPN 2106) . The Net antibody (#375) and the secondary antibodies were described previously (Maira et al., 1996) . Mouse anti-GMP-1 (SUMO-1) (Clone 21C7) was from Clinisciences, anti-polyhistidine IgG2a clone HIS-1 from Sigma, and HPR-labelled protein A from Amersham.
Co-immunoprecipitation
COS-7 cells were harvested in cold PBS, lysed in 100 ml per 9 cm plate of 10 mM Tris-HCl (pH 7.9), 1% SDS, 20 mM Nethyl maleimide, 0.4 mM PMSF, and immediately boiled for 15 min, followed by dilution with the IP buffer to 0.1% SDS prior to immunoprecipitation. Cell lysates were cleared by centrifugation (10 min at 10 000 g) and 300 mg of protein was preincubated for 30 min at 41C with 40 ml of protein GSepharose (50% suspension in 0.1% gelatine). The beads were removed, extracts split into two and incubated for 2 h at 41C with either 5 ml of purified polyclonal anti-Net (#375) or 5 ml of monoclonal anti-polyhistidine clone HIS-1 (Sigma) in a final volume of 1 ml of NET (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP40, 1 mM EDTA, and 0.25% gelatine), followed by 1 h at 41C with 40 ml of protein G-Sepharose. The beads were washed three times with NET buffer. Proteins were fractionated by SDS-PAGE, transferred to nitrocellulose membranes, and analysed by immunoblotting (see above). For endogenous sumoylated Net, NIH3T3 cells (7.5 Â 10 7 ) were lysed in 750 ml of 10 mM Tris-HCl (pH 7.5), 1% SDS, 20 mM N-ethyl maleimide, boiled for 15 min, diluted 10 times with NET buffer containing 1 mM DTT, 1 mM PMSF and protease inhibitors, and precleared with 150 ml of protein G-Sepharose (50% slurry) for 30 min at 41C. The lysates (1.5 ml) were immunoprecipitated with 5 mg monoclonal antibodies anti-SUMO (Zymed 21C7) or nonspecific anti-Gal4 (IGBMC 2GV3/3GV2) for 2 h at 41C with rocking, and incubated with 30 ml of protein G-Sepharose for 1.5 h at 41C with rocking. The beads were washed three times with 1 ml NET buffer and resuspended with 40 ml of 2 Â SDS-loading buffer. Western blots were analysed with anti-Net antibodies (#1996).
